This topic contains a solution. Click here to go to the answer

Author Question: A patient with cirrhosis has begun displaying signs and symptoms of hepatic encephalopathy. The ... (Read 65 times)

renzo156

  • Hero Member
  • *****
  • Posts: 526
A patient with cirrhosis has begun displaying signs and symptoms of hepatic encephalopathy. The nurse prepares to administer lactulose per the prescriber's order. The nurse understands that this drug has been ordered to
 
  a. reduce cerebral edema.
  b. reduce abdominal ascites.
  c. lower ammonia levels.
  d. reduce the hepatic enzymes.

Question 2

The nurse, who is caring for a patient with constipation, is preparing to administer morning medications.
 
  The nurse determines that concurrent drug administration of which of the following medications most likely would contribute to constipation? (Select all that apply.)
  a. Oxycodone/acetaminophen (Percocet)
  b. Aluminum hydroxide
  c. Benztropine (Cogentin)
  d. Ranitidine (Zantac)
  e. Diazepam (Valium)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

zoeyesther

  • Sr. Member
  • ****
  • Posts: 315
Answer to Question 1

ANS: C
Lactulose is the only laxative known to lower ammonia levels in patients with portal hypertension and hepatic encephalopathy secondary to liver disease.
Lactulose does not work to reduce cerebral edema, nor is there any indication the patient is experiencing it.
Lactulose does not work to reduce abdominal ascites.
Lactulose does not reduce liver enzymes.

Answer to Question 2

ANS: A, B, C
Drugs that most likely would contribute to constipation are the opioids (oxycodone/acetaminophen), anticholinergics (benztropine), and some antacids (aluminum hydroxide).
Ranitidine and diazepam are not associated with constipation.




renzo156

  • Member
  • Posts: 526
Reply 2 on: Jul 23, 2018
Excellent


jojobee318

  • Member
  • Posts: 298
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Earwax has antimicrobial properties that reduce the viability of bacteria and fungus in the human ear.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Malaria mortality rates are falling. Increased malaria prevention and control measures have greatly improved these rates. Since 2000, malaria mortality rates have fallen globally by 60% among all age groups, and by 65% among children under age 5.

Did you know?

People about to have surgery must tell their health care providers about all supplements they take.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

For a complete list of videos, visit our video library